Cargando…
Qualifying and quantifying the precision medicine rhetoric
BACKGROUND: With the rise of precision medicine efforts worldwide, our study objective was to describe and map the emerging precision medicine landscape. A Google search was conducted between June 19, 2017 to July 20, 2017 to examine how “precision medicine” and its analogous terminology were used t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858780/ https://www.ncbi.nlm.nih.gov/pubmed/31730456 http://dx.doi.org/10.1186/s12864-019-6242-8 |
_version_ | 1783471028146536448 |
---|---|
author | Lee, Jasmine Hamideh, Dina Nebeker, Camille |
author_facet | Lee, Jasmine Hamideh, Dina Nebeker, Camille |
author_sort | Lee, Jasmine |
collection | PubMed |
description | BACKGROUND: With the rise of precision medicine efforts worldwide, our study objective was to describe and map the emerging precision medicine landscape. A Google search was conducted between June 19, 2017 to July 20, 2017 to examine how “precision medicine” and its analogous terminology were used to describe precision medicine efforts. Resulting web-pages were reviewed for geographic location, data type(s), program aim(s), sample size, duration, and the key search terms used and recorded in a database. Descriptive statistics were applied to quantify terminology used to describe specific precision medicine efforts. Qualitative data were analyzed for content and patterns. RESULTS: Of the 108 programs identified through our search, 84% collected only biospecimen(s) and, of those that collected at least two data types, 42% mentioned both Electronic Health Records (EHR) and biospecimen. Given the majority of efforts limited to biospecimen(s) use, genetic research seems to be prioritized in association with precision medicine. Roughly, 54% were found to collect two or more data types, which limits the output of information that may contribute to understanding of the interplay of genetic, lifestyle, and environmental factors. Over half were government-funded with roughly a third being industry-funded. Most initiatives were concentrated in the United States, Europe, and Asia. CONCLUSIONS: To our knowledge, this is the first study to map and qualify the global precision medicine landscape. Our findings reveal that precision medicine efforts range from large model cohort studies involving multidimensional, longitudinal data to biorepositories with a collection of blood samples. We present a spectrum where past, present, and future PM-like efforts can fall based on their scope and potential impact. If precision medicine is based on genes, lifestyle and environmental factors, we recommend programs claiming to be precision medicine initiatives to incorporate multidimensional data that can inform a holistic approach to healthcare. |
format | Online Article Text |
id | pubmed-6858780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68587802019-11-29 Qualifying and quantifying the precision medicine rhetoric Lee, Jasmine Hamideh, Dina Nebeker, Camille BMC Genomics Research Article BACKGROUND: With the rise of precision medicine efforts worldwide, our study objective was to describe and map the emerging precision medicine landscape. A Google search was conducted between June 19, 2017 to July 20, 2017 to examine how “precision medicine” and its analogous terminology were used to describe precision medicine efforts. Resulting web-pages were reviewed for geographic location, data type(s), program aim(s), sample size, duration, and the key search terms used and recorded in a database. Descriptive statistics were applied to quantify terminology used to describe specific precision medicine efforts. Qualitative data were analyzed for content and patterns. RESULTS: Of the 108 programs identified through our search, 84% collected only biospecimen(s) and, of those that collected at least two data types, 42% mentioned both Electronic Health Records (EHR) and biospecimen. Given the majority of efforts limited to biospecimen(s) use, genetic research seems to be prioritized in association with precision medicine. Roughly, 54% were found to collect two or more data types, which limits the output of information that may contribute to understanding of the interplay of genetic, lifestyle, and environmental factors. Over half were government-funded with roughly a third being industry-funded. Most initiatives were concentrated in the United States, Europe, and Asia. CONCLUSIONS: To our knowledge, this is the first study to map and qualify the global precision medicine landscape. Our findings reveal that precision medicine efforts range from large model cohort studies involving multidimensional, longitudinal data to biorepositories with a collection of blood samples. We present a spectrum where past, present, and future PM-like efforts can fall based on their scope and potential impact. If precision medicine is based on genes, lifestyle and environmental factors, we recommend programs claiming to be precision medicine initiatives to incorporate multidimensional data that can inform a holistic approach to healthcare. BioMed Central 2019-11-15 /pmc/articles/PMC6858780/ /pubmed/31730456 http://dx.doi.org/10.1186/s12864-019-6242-8 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lee, Jasmine Hamideh, Dina Nebeker, Camille Qualifying and quantifying the precision medicine rhetoric |
title | Qualifying and quantifying the precision medicine rhetoric |
title_full | Qualifying and quantifying the precision medicine rhetoric |
title_fullStr | Qualifying and quantifying the precision medicine rhetoric |
title_full_unstemmed | Qualifying and quantifying the precision medicine rhetoric |
title_short | Qualifying and quantifying the precision medicine rhetoric |
title_sort | qualifying and quantifying the precision medicine rhetoric |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858780/ https://www.ncbi.nlm.nih.gov/pubmed/31730456 http://dx.doi.org/10.1186/s12864-019-6242-8 |
work_keys_str_mv | AT leejasmine qualifyingandquantifyingtheprecisionmedicinerhetoric AT hamidehdina qualifyingandquantifyingtheprecisionmedicinerhetoric AT nebekercamille qualifyingandquantifyingtheprecisionmedicinerhetoric |